These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1972879)

  • 1. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease.
    Genest JJ; Ordovas JM; McNamara JR; Robbins AM; Meade T; Cohn SD; Salem DN; Wilson PW; Masharani U; Frossard PM
    Atherosclerosis; 1990 May; 82(1-2):7-17. PubMed ID: 1972879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MspI restriction fragment length polymorphism 3' to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Civeira F; Genest J; Pocovi M; Salem DN; Herbert PN; Wilson PW; Schaefer EJ; Ordovas JM
    Atherosclerosis; 1992 Feb; 92(2-3):165-76. PubMed ID: 1352975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A1 gene polymorphisms and risk of early coronary disease.
    Reguero JR; Cubero GI; Batalla A; Alvarez V; Hevia S; Cortina A; Coto E
    Cardiology; 1998 Dec; 90(3):231-5. PubMed ID: 9892774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA polymorphisms of the apolipoprotein B gene (XbaI, EcoRI, and MspI RFLPs) in Norwegians at risk of atherosclerosis and healthy controls.
    Delghandi M; Thangarajah R; Nilsen M; Grimsgaard S; Bønaa KH; Tonstad S; Jørgensen L
    Acta Cardiol; 1999 Aug; 54(4):215-25. PubMed ID: 10511898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Ordovas JM; Civeira F; Genest J; Craig S; Robbins AH; Meade T; Pocovi M; Frossard PM; Masharani U; Wilson PW
    Atherosclerosis; 1991 Mar; 87(1):75-86. PubMed ID: 1678604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymorphisms of the apolipoprotein B gene in Chinese coronary artery disease patients.
    Saha N; Tong MC; Tay JS; Jeyaseelan K; Humphries SE
    Clin Genet; 1992 Oct; 42(4):164-70. PubMed ID: 1358487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration.
    Wile DB; Barbir M; Gallagher J; Myant NB; Ritchie CD; Thompson GR; Humphries SE
    Atherosclerosis; 1989 Jul; 78(1):9-18. PubMed ID: 2569310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of apolipoprotein-B gene is associated with obesity, high blood cholesterol levels, and increased risk of coronary heart disease.
    Rajput-Williams J; Knott TJ; Wallis SC; Sweetnam P; Yarnell J; Cox N; Bell GI; Miller NE; Scott J
    Lancet; 1988 Dec 24-31; 2(8626-8627):1442-6. PubMed ID: 2904569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the apolipoprotein B-100 gene: association with plasma lipid concentration and coronary artery disease.
    Puri RD; Tewari S; Sinha N; Ramesh V; Khan F; Singh VP; Agrawal S
    Indian Heart J; 2003; 55(1):60-4. PubMed ID: 12760590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: the Cardiovascular Risk in Young Finns Study.
    Porkka KV; Taimela S; Kontula K; Lehtimäki T; Aalto-Setälä K; Akerblom HK; Viikari JS
    Clin Genet; 1994 Mar; 45(3):113-21. PubMed ID: 7913004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B-100 and in the 5' flanking region of the insulin gene as possible markers of coronary heart disease.
    Wick U; Witt E; Engel W
    Clin Genet; 1995 Apr; 47(4):184-90. PubMed ID: 7628120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease.
    Myant NB; Gallagher J; Barbir M; Thompson GR; Wile D; Humphries SE
    Atherosclerosis; 1989 Jun; 77(2-3):193-201. PubMed ID: 2568839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.
    Wang XL; Liu SX; McCredie RM; Wilcken DE
    J Clin Invest; 1996 Jul; 98(2):372-7. PubMed ID: 8755647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
    Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
    Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women.
    Lehtinen S; Lehtimäki T; Sisto T; Salenius JP; Nikkilä M; Jokela H; Koivula T; Ebeling F; Ehnholm C
    Atherosclerosis; 1995 Apr; 114(1):83-91. PubMed ID: 7605379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [XbaI polymorphism of apolipoprotein B gene in a Tunisian population: alleles frequencies and relationship with plasma lipid parameters].
    Kallel A; Jemaa R; Feki M; El Asmi M; Souissi M; Sanhaji H; Haj-Taieb S; Omar S; Kaabachi N
    Ann Biol Clin (Paris); 2007; 65(3):265-70. PubMed ID: 17502298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA polymorphisms of the apolipoprotein B and A-I/C-III genes are associated with variations of serum low density lipoprotein cholesterol level in childhood.
    Aalto-Setälä K; Viikari J; Akerblom HK; Kuusela V; Kontula K
    J Lipid Res; 1991 Sep; 32(9):1477-87. PubMed ID: 1684378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B 3' hypervariable repeat genotype: association with plasma lipid concentration, coronary artery disease, and other restriction fragment polymorphisms.
    Wu JH; Chern MS; Lo SK; Wen MS; Kao JT
    Clin Chem; 1996 Jun; 42(6 Pt 1):927-32. PubMed ID: 8665685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.